Skip to content

A multicenter randomized controlled clinical study of Haitong Pi Formula Cataplasms in the treatment of lumbar disc herniation

A multicenter randomized controlled clinical study of Haitong Pi Formula Cataplasms in the treatment of lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000468
Enrollment
Unknown
Registered
2024-09-22
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Test Group: Lumbar spine manipulation of Qinggong Bone-setting method combined with Haitong Pi Fang Formula Cataplasms

Sponsors

Wangjing Hospital Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Complies with the diagnosis of lumbar disc herniation and the differentiation of cold dampness obstruction syndrome; (2) Age between 40-60 years old; (3) Not receiving any other conservative treatment that may affect the results of this trial in the past two weeks; (4) Sign the relevant informed consent form.

Exclusion criteria

Exclusion criteria: (1) Combining other medications may affect the trial results; (2) Individuals with previous spinal infections traumatic fractures tumors tuberculosis severe osteoporosis ankylosing spondylitis and other conditions that may affect the results of this experiment; (3) Individuals with contraindications to manual manipulation such as those with skin damage or skin diseases at the manipulation site; (4) Individuals with contraindications for the use of topical medications such as those with local skin lesions or wounds; (5) Groups that cannot cooperate with manual therapy such as pregnant and lactating women malignant tumors and other serious systemic diseases; (6) Patients in the acute phase and/or VAS score>7.

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Index;

Secondary

MeasureTime frame
Prothrombin time;lactatedehydrogenase;Quantitative checklist of typical signs;Visual Analogue Scales;Actived partial thrombo plastin time;lumbar spine mobility;Creatine Kinase;Lumbar pressure pain test;

Countries

China

Contacts

Public ContactQing Zhang

Wangjing Hospital Chinese Academy of Traditional Chinese Medicine

zhangqinggys@163.com13641278072

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026